Anatel Plus Tablet 80/12.5 mg

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with water, regardless of meal. Before switching to this medication with fixed doses of each ingredient, it is recommended to adjust the individual dosages based on patient need. When clinically appropriate, direct conversion from monotherapy to this medication can also be considered. - Telmisartan / Hydrochlorothiazide combination 40/12.5 mg can be given to patients whose blood pressure is not adequately controlled with telmisartan 40 mg. - Telmisartan / Hydrochlorothiazide combination 80/12.5 mg can be given to patients whose blood pressure is not adequately controlled with telmisartan 80 mg. - Telmisartan / Hydrochlorothiazide combination 80/25 mg can be given to patients whose blood pressure is not adequately controlled with the combination of telmisartan 80 mg and hydrochlorothiazide 12.5 mg. Before starting this medication, sodium or volume depletion should be corrected. Patients with renal impairment For patients with mild to moderate renal impairment, dosage adjustment is not required. This medication should not be given to patients with severe renal impairment (creatinine clearance <30 mL/min). Regular monitoring of kidney function is recommended. Hepatic impairment patients For patients with mild to moderate hepatic impairment, this medication should be administered with caution. The daily dose should not exceed 40/12.5 mg. This medication should not be given to patients with severe hepatic impairment (refer to precautions 2). Thiazide diuretics should be administered with caution to patients with liver dysfunction. Elderly Dose modification is not necessary. Pediatric The safety and efficacy of this medication have not been established in individuals under 18 years of age.

Child dose

The safety and efficacy of this medication have not been established in individuals under 18 years of age.

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. Patients with allergies to this medication's components, pregnant women, breastfeeding women, and those with severe liver or kidney disease should not take this medication. Elderly patients or those with high potassium levels or poor liver function, as well as patients with heart valve disease or cardiomyopathy, should use this medication with caution. The hydrochlorothiazide component may increase the risk of skin cancer by making the skin sensitive to sunlight, so UV protection and skin examinations are necessary during use. Various side effects such as dizziness, hypotension, electrolyte imbalance, liver dysfunction, rash, etc., may occur while taking this medication. Any unusual symptoms should be reported to a doctor immediately. It is particularly important for patients with poor kidney function to have regular blood tests to monitor potassium, creatinine, and other levels. Interactions with other antihypertensive agents, diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., may occur, so inform the doctor of any other medications being taken. Dizziness or drowsiness may occur during driving or operating machinery, so caution is advised. Women planning to become pregnant are recommended to use safer alternative therapies rather than this medication. The safety and efficacy of this medication have not been established in children.

Serious side effects

• Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, paleness, severe allergic reactions
• Severe rash with high fever, blistering, skin peeling, oral/ocular mucosal pain, severe skin adverse reactions
• Shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever
• Skin or eyes turning yellow, severe lethargy, liver problems (jaundice)
• Sudden and severe headaches, thunderclap headache, vomiting

Mild side effects

• Bronchitis
• pharyngitis
• sinusitis
• hypokalemia
• hyperuricemia
• hyponatremia
• anxiety
• depression
• insomnia
• sleep disturbances

This medication should be stored in a tightly closed container to prevent air or moisture from entering. A storage temperature between 1 degree Celsius and 30 degrees Celsius is recommended.

Appearance

White or almost white, biconvex, round tablet

Package unit

30 tablets (10 tablets/blister × 3)